Search

Displaying results 4911 - 4920 of 7503 in total
  1. Drug

    Mus musculus skin

    go.drugbank.com/drugs/DB10412
    Approved

    Mus musculus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  2. Drug

    Cavia porcellus skin

    go.drugbank.com/drugs/DB10416
    Approved

    Cavia porcellus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  3. Drug

    Meriones unguiculatus skin

    go.drugbank.com/drugs/DB10603
    Approved

    Meriones unguiculatus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  4. Drug

    Capra hircus skin

    go.drugbank.com/drugs/DB10604
    Approved

    Capra hircus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  5. Drug

    Oryctolagus cuniculus skin

    go.drugbank.com/drugs/DB10607
    Approved

    Oryctolagus cuniculus skin or pelt is used in allergenic testing.

    Categories: Non-Standardized Animal Skin Allergenic Extract
  6. Drug

    Canis lupus familiaris hair

    go.drugbank.com/drugs/DB10867
    Approved

    Domestic dog hair is used in allergenic testing.

    Categories: Non-Standardized Animal Hair Allergenic Extract
  7. Drug

    Canis lupus familiaris dander

    go.drugbank.com/drugs/DB11018
    Approved

    Canis lupus familiaris dander is the dander of Canis lupus familiaris. Canis lupus familiaris dander is used in allergenic testing.

    Categories: Non-Standardized Animal Dander Allergenic Extract
  8. Drug

    Camponotus pennsylvanicus

    go.drugbank.com/drugs/DB14710
    Approved

    Camponotus pennsylvanicus allergenic extract is used in allergenic testing.

    Categories: Non-Standardized Insect Venom Allergenic Extract
  9. Drug

    KBP-COVID-19

    go.drugbank.com/drugs/DB15858
    Investigational

    The KBP-201 COVID-19 Vaccine was developed by British American Tobacco’s (BAT) U.S. biotech subsidiary, Kentucky BioProcessing (KBP). … As of July 2020, KBP is conducting a Phase 1/2 clinical trial to evaluate the safety and immunogenicity of KBP-COVID-19 vaccine in healthy patients (NCT04473690).

  10. Drug

    SPC2968

    go.drugbank.com/drugs/DB06351
    Investigational

    It was under investigation in clinical trial NCT02564614 (A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult